Laboratory Reference Grade Compounds
⚡ Multi-Compound Synergy Engine · 15% Kit Savings · Live Stoichiometry

Peptide Stacks & Regimens Studio

Precision multi-peptide research cycles engineered with separate physical lyophilized vials. Features interactive diluent stoichiometry, live U-100 syringe graduation visualizers, synchronized 7-day administration schedules, and 1-click complete kit fulfillment.

💧Stoichiometry Station
💉U-100 Meniscus Visualizer
📅7-Day AM/PM Schedule Sync
📦1-Click Medusa Kit Builder
⚡ Interactive Stacking & Compatibility Studio·Database-Grounded Multi-Product Engine
30 Compounds · 0 in Active Regimen

Peptide Stacking & Multi-Product Compatibility Studio

Evaluate whether multiple separate products are safe, synergistic, or contraindicated to run together in your research protocol. Search our catalog, discover verified compatible stacking partners, and generate synchronized co-administration protocols.

1. Stack:Multi-product protocol: checking if separate vials are safe & synergistic to run together.
2. Blend:Single physical vial: active peptides pre-mixed & lyophilized together in 1 cake.
3. Bundle:Commercial selling offer: 15% discount for buying all required vials & supplies together.
🚀 Quick Verified Regimen Presets:
🧪 Active Selected Stack Compounds (0 / 4 Vials):
Click any tag to focus or remove (min 1, max 4)

🔍 Search Peptides to Stack:

Type any compound name, target receptor, or biological indication to see stack options.

Filter:
BPC-157· Tissue Repair & Healing
Target: VEGFR2, FAK-Paxillin, Growth Hormone Receptor Upregulation
TB-500· Tissue Repair & Healing
Target: Actin-Sequestering Peptide (G-Actin / F-Actin balance)
CJC-1295 No DAC· Somatotropic GH Axis
Target: GHRH Receptor (Growth Hormone Releasing Hormone)
Ipamorelin· Somatotropic GH Axis
Target: GHS-R1a (Ghrelin Receptor / Growth Hormone Secretagogue)
Tirzepatide· Metabolic & Incretin
Target: Dual GLP-1 & GIP Receptor Co-Agonist
Semaglutide· Metabolic & Incretin
Target: Selective GLP-1 Receptor Agonist
Retatrutide· Metabolic & Incretin
Target: Triple GLP-1 / GIP / Glucagon Receptor Agonist
AOD-9604· Metabolic & Lipolysis
Target: Beta-3 Adrenergic Receptor Activation (GH C-Terminal 177-191)
GHK-Cu· Cellular Remodeling & Cosmetic
Target: Extracellular Matrix Fibroblast Signaling & Gene Expression Reset
Epithalon· Cellular Longevity & Telomeres
Target: Pineal Gland Epithalamic Peptide / Telomerase Activator
NAD+· Cellular Bioenergetics
Target: Mitochondrial Complex I / Sirtuin Sirt1-7 / PARP Cofactor
Glutathione· Antioxidant & Detoxification
Target: Intracellular Redox Buffer / Phase II Hepatic Conjugation
Semax· Cognitive & Neurogenesis
Target: TrkB / BDNF / Melanocortin Receptors (Non-hormonotropic)
Selank· Cognitive & Anxiolytic
Target: GABA-A / Enkephalinase Inhibition / IL-6 Modulation
Melanotan II· Photoprotection & Melanogenesis
Target: MC1R, MC3R, MC4R, MC5R Agonist
PT-141· Sexual Function & Melanocortin
Target: Selective Central MC4R & MC3R Agonist
GHRP-2· GH Secretagogue
Target: GHS-R1a Non-Selective
GHRP-6· GH Secretagogue
Target: GHS-R1a Non-Selective
Cagrilintide· Metabolic & Incretin
Target: Amylin (AMY1-3) & Calcitonin Receptors
Orforglipron· Metabolic & Incretin
Target: Non-Peptide GLP-1 Receptor Small Molecule
Pemvidutide· Metabolic & Incretin
Target: Balanced 1:1 GLP-1 and Glucagon Receptor Dual Agonist
PEG-MGF· Anabolic & Satellite Cell Activation
Target: IGF-1Ec C-Terminal Autocrine Pathway
IGF-1 LR3· Anabolic & Cellular Hyperplasia
Target: IGF-1 Receptor (IGF-1R) with Reduced Binding Protein Affinity
Follistatin-344· Myostatin & Muscle Hypertrophy
Target: Myostatin (GDF-8) & Activin-A Neutralization
BPC-157 Arg· Tissue Repair & Healing
Target: VEGFR2, FAK-Paxillin, Nitric Oxide Synthesis
Vesugen· Vascular & Microcirculation
Target: Endothelial Epigenetic Histone Complex
Cardiogen· Cardiovascular Repair
Target: Myocardial Epigenetic Transcription
Tesamorelin· Somatotropic GH Axis
Target: Pituitary GHRH Receptor
Thymulin· Immune & Neuro-Inflammation
Target: Thymocyte Surface Receptors & Neuro-Immune Axis
SLU-PP-332· Metabolic & Mitochondrial
Target: Estrogen-Related Receptor Alpha (ERRα)
🌟 Stacking Partner Recommendations for:

Peptides that can be safely stacked with BPC-157 (Pentadecapeptide)

Receptor: VEGFR2
🟢 Highly Synergistic Partners (Multi-Pathway Amplification):
TB-500 (Thymosin Beta-4 Frag)+98 Synergy
The Wolverine Stack: Dual Microvascular & Actin Remodeling Synergy

BPC-157 acts locally by accelerating microvascular angiogenesis via VEGFR2 and stabilizing granulation tissue, while TB-500 sequesters G-actin to drive rapid systemic cell migration and prevent fibrous adhesion/scar formation.

Timing: Administer both during the same cycle
GHK-Cu (Copper Tripeptide-1)+93 Synergy
Microvascular & Extracellular Matrix Remodeling Synergy

BPC-157 rapidly generates fresh capillary networks (angiogenesis) to deliver oxygen and amino acids to damaged tissue, while GHK-Cu signals fibroblasts to synthesize new type I/III collagen and elastin while inhibiting TGF-beta scar formation.

Timing: Administer in separate SubQ injections daily
Tirzepatide+91 Synergy
Incretin GI Tolerance & Mucosal Cytoprotection Stack

GLP-1 receptor agonists can cause transient delayed gastric emptying, nausea, and mucosal irritation. BPC-157 provides direct cytoprotective benefits across gastric epithelium, reducing gut discomfort while incretins drive metabolic weight loss.

Timing: Tirzepatide: Weekly SubQ
Semaglutide+90 Synergy
GLP-1 Gut Barrier & Epithelial Recovery Stack

Semaglutide delays gastric motility to enhance satiety. BPC-157 upregulates tight junction proteins (Claudin, Zonula Occludens) and nitric oxide synthesis, minimizing digestive cramping and acid reflux in GLP-1 naive subjects.

Timing: Semaglutide: Weekly SubQ
🔵 Compatible Regimen Partners (Non-Interfering Pathways):
CJC-1295 No DACCompatible

Stimulates anterior pituitary GH transcription & physiological pulsatile release

Somatotropic GH Axis
IpamorelinCompatible

Triggers amplified somatotrope vesicular release without raising prolactin or cortisol

Somatotropic GH Axis
RetatrutideCompatible

Triple incretin co-agonism with enhanced hepatic lipid oxidation and energy expenditure

Metabolic & Incretin
AOD-9604Compatible

Stimulates lipolysis in white adipose tissue and inhibits lipogenesis without altering IGF-1 or glycemic levels

Metabolic & Lipolysis
EpithalonCompatible

Upregulates telomerase reverse transcriptase (TERT), normalizes pineal melatonin secretion and circadian chromatin

Cellular Longevity & Telomeres
NAD+Compatible

Cellular ATP production, oxidative phosphorylation, PARP DNA repair enzyme activation

Cellular Bioenergetics
Need in-depth single-vial titration schedules or printable lab dossiers?
Related Research Resources

Explore Companion Dosage Charts & Compound Monographs

Master Dosage ChartHead-to-Head ComparisonsCoA Directory